These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1170312)

  • 41. [Evolution of the concentration of valtrates in Valeriana procurrens Wallr. cultivated in conditioned media].
    Mélotte R
    J Pharm Belg; 1973; 28(3):373-83. PubMed ID: 4733874
    [No Abstract]   [Full Text] [Related]  

  • 42. [Dynamics of the seasonal accumulation of the main groups of chemical compounds of Valeriana stolonifera czern].
    Kornievsk'iĭ IuI; Koreshchuk KE
    Farm Zh; 1971; 26(2):67-70. PubMed ID: 5152491
    [No Abstract]   [Full Text] [Related]  

  • 43. HPLC analysis of valepotriates in the North American genera Plectritis and Valeriana.
    Foerster W; Becker H; Rodriguez E
    Planta Med; 1984 Feb; 50(1):7-9. PubMed ID: 6739575
    [No Abstract]   [Full Text] [Related]  

  • 44. [Procedure for measuring the value of valproates in pharmacopoeia-prescribed valeriana tinctures].
    Liptákné CE; Pethes E
    Acta Pharm Hung; 1978 Jul; 48(4):161-7. PubMed ID: 707108
    [No Abstract]   [Full Text] [Related]  

  • 45. [Seasonal changes of valeropotriates in native Valeriana procurrens Wallr].
    Chapelle JP
    J Pharm Belg; 1972; 27(5):570-6. PubMed ID: 4660645
    [No Abstract]   [Full Text] [Related]  

  • 46. [Linarin-isovalerianate, a currently unknown flavonoid from Valeriana wallichii D.C. 6. Report on the active substances of Valeriana].
    Thies PW
    Planta Med; 1968 Dec; 16(4):363-71. PubMed ID: 5734374
    [No Abstract]   [Full Text] [Related]  

  • 47. To the pharmacology of iridoids.
    Petkov V; Manolov P
    Agressologie; 1975; 16 Spec No B():25-30. PubMed ID: 1232824
    [No Abstract]   [Full Text] [Related]  

  • 48. [Studies on the chemical constituents of rutaceous plants. XXI. The chemical constituents of Xanthoxylum arnottianum Maxim. (2). Isolation of the chemical constituents of the xylem of stems (author's transl)].
    Ishii H; Hosoya K; Ishikawa T; Ueda E; Haginiwa J
    Yakugaku Zasshi; 1974 Mar; 94(3):322-31. PubMed ID: 4859124
    [No Abstract]   [Full Text] [Related]  

  • 49. [Studies on HPLC fingerprint of the hydrophilic constituents of Valeriana medicinal plants].
    Shi JL; Liu Y; Xiao PG
    Zhongguo Zhong Yao Za Zhi; 2005 Mar; 30(6):426-9. PubMed ID: 15810445
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Clinical observations on the use of a new tranquilizing agent].
    Buchthala M
    Hippokrates; 1968 Jun; 39(12):466-8. PubMed ID: 5732425
    [No Abstract]   [Full Text] [Related]  

  • 51. [Proposals for methods of analyzing F.G.N. preparations. Antispastic tablets].
    De Santis A; Re Garbagnati V
    Boll Chim Farm; 1967 Jan; 106(1):51-3. PubMed ID: 5608606
    [No Abstract]   [Full Text] [Related]  

  • 52. [Experimental studies of the effects of Seda-Kneipp on the sleep of sleep disturbed subjects; implications for the treatment of different sleep disturbances (author's transl)].
    Müller-Limmroth W; Ehrenstein W
    Med Klin; 1977 Jun; 72(25):1119-25. PubMed ID: 196167
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Analysis of constituents in crude drugs by high-speed liquid chromatography. I. Quantitative analysis of paeoniflorin in paeony roots (author's transl)].
    Shimizu M; Hashimoto T; Ishikawa S; Kurosaki F; Morita N
    Yakugaku Zasshi; 1979 Apr; 99(4):432-5. PubMed ID: 480142
    [No Abstract]   [Full Text] [Related]  

  • 54. [Effects of Valeriana officinalis L extract on cardiovascular system].
    Zhang BH; Meng HP; Wang T; Dai YC; Shen J; Tao C; Wen SR; Qi Z; Ma L; Yuan SH
    Yao Xue Xue Bao; 1982 May; 17(5):382-4. PubMed ID: 7180472
    [No Abstract]   [Full Text] [Related]  

  • 55. [Dependence of the valepotriate and essential oil content in Valeriana officinalis L.s.l. on various exogenous and endogenous factors].
    Wagner H; Schaette R; Hörhammer L; Hölzl J
    Arzneimittelforschung; 1972 Jul; 22(7):1204-9. PubMed ID: 4678131
    [No Abstract]   [Full Text] [Related]  

  • 56. [The effect of degradation products of valepotriates on the motor activity of light-dark synchronized mice].
    Veith J; Schneider G; Lemmer B; Willems M
    Planta Med; 1986 Jun; (3):179-83. PubMed ID: 3749340
    [No Abstract]   [Full Text] [Related]  

  • 57. Psychotropic effects of Japanese valerian root extract.
    Sakamoto T; Mitani Y; Nakajima K
    Chem Pharm Bull (Tokyo); 1992 Mar; 40(3):758-61. PubMed ID: 1611689
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Studies on origin of Japanese Chuanxiong. I. Angelica (author's transl)].
    Suk KK; Nitta A; Konoshima M
    Yakugaku Zasshi; 1974 Jul; 94(7):865-71. PubMed ID: 4474398
    [No Abstract]   [Full Text] [Related]  

  • 59. [Studies on the constituents of medicinal plants in Hokkaido. I. On the whole herb of Swertia tetrapetala Pall. (1) (author's transl)].
    Agata I; Sekizaki H; Sakushima A; Nishibe S; Hisada S; Kimura K
    Yakugaku Zasshi; 1981 Nov; 101(11):1067-71. PubMed ID: 7343662
    [No Abstract]   [Full Text] [Related]  

  • 60. [The transition of psychotropic drugs in Japanese Pharmacopoeia (JP) (Part 6): the knowledge and judgment about the sort as the medicine on valerianae radix].
    Yanagisawa K; Yamada M; Matsumoto Y
    Yakushigaku Zasshi; 1993; 28(1):12-9. PubMed ID: 11639714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.